Transcriptional profile of primary astrocytes expressing ALS-linked mutant SOD1
- PMID: 18683239
- PMCID: PMC4048747
- DOI: 10.1002/jnr.21797
Transcriptional profile of primary astrocytes expressing ALS-linked mutant SOD1
Abstract
Amyotrophic lateral sclerosis (ALS) is caused by the progressive degeneration of motor neurons. Mutations in the Cu/Zn superoxide dismutase (SOD1) are found in approximately 20% of patients with familial ALS. Mutant SOD1 causes motor neuron death through an acquired toxic property. Although the molecular mechanism underlying this toxic gain-of-function remains unknown, evidence support the role of mutant SOD1 expression in nonneuronal cells in shaping motor neuron degeneration. We have previously found that in contrast to nontransgenic cells, SOD1(G93A)-expressing astrocytes induced apoptosis of cocultured motor neurons. This prompted us to investigate whether the effect on motor neuron survival was related to a change in the gene expression profile. Through high-density oligonucleotide microarrays, we found changes in the expression of genes involved in transcription, signaling, cell proliferation, extracellular matrix synthesis, response to stress, and steroid and lipid metabolism. The most up-regulated gene was decorin (Dcn), a small multifunctional extracellular proteoglycan. Down-regulated genes included the insulin-like growth factor-1 receptor (Igf-1r) and the RNA binding protein ROD1. Rod1 was also found down-regulated in purified motor neurons expressing SOD1(G93A). Changes in the expression of Dcn, Igf-1r, and Rod1 were found in the spinal cord of asymptomatic animals, suggesting these changes occur before overt neuronal degeneration and potentially influence astrocyte-motor neuron interaction in the course of the disease. The astrocyte-specific gene expression profile might contribute to the identification of possible candidates for cell type-specific therapies in ALS.
(c) 2008 Wiley-Liss, Inc.
Figures
Similar articles
-
Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells.Cell Stem Cell. 2008 Dec 4;3(6):649-57. doi: 10.1016/j.stem.2008.10.001. Cell Stem Cell. 2008. PMID: 19041781
-
Mitochondrial dysfunction in SOD1G93A-bearing astrocytes promotes motor neuron degeneration: prevention by mitochondrial-targeted antioxidants.J Neurosci. 2008 Apr 16;28(16):4115-22. doi: 10.1523/JNEUROSCI.5308-07.2008. J Neurosci. 2008. PMID: 18417691 Free PMC article.
-
Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS.Brain. 2005 Jul;128(Pt 7):1686-706. doi: 10.1093/brain/awh503. Epub 2005 May 4. Brain. 2005. PMID: 15872021
-
Astrocyte-Neuron Interactions Contributing to Amyotrophic Lateral Sclerosis Progression.Adv Neurobiol. 2024;39:285-318. doi: 10.1007/978-3-031-64839-7_12. Adv Neurobiol. 2024. PMID: 39190080 Review.
-
Why should we care about astrocytes in a motor neuron disease?Front Mol Med. 2023 Jan 23;3:1047540. doi: 10.3389/fmmed.2023.1047540. eCollection 2023. Front Mol Med. 2023. PMID: 39086676 Free PMC article. Review.
Cited by
-
The potential of GPNMB as novel neuroprotective factor in amyotrophic lateral sclerosis.Sci Rep. 2012;2:573. doi: 10.1038/srep00573. Epub 2012 Aug 13. Sci Rep. 2012. PMID: 22891158 Free PMC article.
-
Astrogliosis in amyotrophic lateral sclerosis: role and therapeutic potential of astrocytes.Neurotherapeutics. 2010 Oct;7(4):471-81. doi: 10.1016/j.nurt.2010.05.012. Neurotherapeutics. 2010. PMID: 20880509 Free PMC article. Review.
-
Role and Therapeutic Potential of Astrocytes in Amyotrophic Lateral Sclerosis.Curr Pharm Des. 2017;23(33):5010-5021. doi: 10.2174/1381612823666170622095802. Curr Pharm Des. 2017. PMID: 28641533 Free PMC article. Review.
-
The human G93A-superoxide dismutase-1 mutation, mitochondrial glutathione and apoptotic cell death.Neurochem Res. 2009 Oct;34(10):1847-56. doi: 10.1007/s11064-009-9974-z. Epub 2009 Apr 28. Neurochem Res. 2009. PMID: 19399611 Review.
-
Reactive astrocytes in ALS display diminished intron retention.Nucleic Acids Res. 2021 Apr 6;49(6):3168-3184. doi: 10.1093/nar/gkab115. Nucleic Acids Res. 2021. PMID: 33684213 Free PMC article.
References
-
- Abe K, Pan LH, Watanabe M, Konno H, Kato T, Itoyama Y. Upregulation of protein-tyrosine nitration in the anterior horn cells of amyotrophic lateral sclerosis. Neurol Res. 1997;19:124–128. - PubMed
-
- Almer G, Vukosavic S, Romero N, Przedborski S. Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem. 1999;72:2415–2425. - PubMed
-
- Ang LC, Bhaumick B, Juurlink BH. Neurite promoting activity of insulin, insulin-like growth factor I and nerve growth factor on spinal motoneurons is astrocyte dependent. Brain Res Dev Brain Res. 1993;74:83–88. - PubMed
-
- Ang LC, Bhaumick B, Munoz DG, Sass J, Juurlink BH. Effects of astrocytes, insulin and insulin-like growth factor I on the survival of motoneurons in vitro. J Neurol Sci. 1992;109:168–172. - PubMed
-
- Anneser JM, Cookson MR, Ince PG, Shaw PJ, Borasio GD. Glial cells of the spinal cord and subcortical white matter up-regulate neuronal nitric oxide synthase in sporadic amyotrophic lateral sclerosis. Exp Neurol. 2001;171:418–421. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous